|
Market Closed -
NYSE
23:30:00 02/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 10.62 USD | -3.28% |
|
-5.01% | -28.00% |
| 09-01 | Daxor Corporation Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 07-30 | Daxor Launches Blood Testing Lab in Eastern Kansis | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 4.177 | +7.78% | 3 | ||||||
| - | - | 42 | +13.09% | 1 | ||||
| 1.5 | +14.33% | 2 | ||||||
| 12.05 | +9.85% | 10 | ||||||
| Average | 14.93 | +11.26% | 4 | ||||||
| Weighted average by Cap. | 14.77 | +10.99% | 4 |
- Stock Market
- Stocks
- DXR Stock
- DXR Stock
- Sector Daxor Corporation
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
